Inventor · Pennington, NJ, US

Paul E. Morin

23Patents
9h-index
43Co-inventors
71Inventor score

Filing activity: Apr 19, 2010 → Apr 15, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8067201B2 Methods for protein refolding Chemistry; Metallurgy 51 Active
US8969289B2 Serum albumin binding molecules Chemistry; Metallurgy 40 Active
US9540424B2 Serum albumin binding molecules Chemistry; Metallurgy 26 Active
US9434778B2 Modified FGF-21 polypeptides comprising an internal deletion and uses thereof Chemistry; Metallurgy 17 Active
US10406251B2 PD-L1 binding polypeptides for imaging Physics 14 Active
US9631004B2 Modified FGF-21 polypeptides comprising an internal deletion and uses thereof Chemistry; Metallurgy 11 Active
US10221438B2 Serum albumin binding molecules Chemistry; Metallurgy 10 Active
US10266578B2 Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof Human Necessities 9 Active
US10189883B2 Therapeutic uses of modified FGF-21 polypeptides Chemistry; Metallurgy 9 Active
US10377806B2 Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof Chemistry; Metallurgy 5 Active
US11173219B2 PD-L1 binding polypeptides for imaging Physics 3 Active
US11344639B2 PET imaging with PD-L1 binding polypeptides Chemistry; Metallurgy 3 Active
US10934572B2 Serum albumin binding molecules Chemistry; Metallurgy 2 Active
US11248031B2 Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides Chemistry; Metallurgy 2 Active
US12247058B2 Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof Chemistry; Metallurgy 0 Active
US11364281B2 Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Human Necessities 0 Active
US11623013B2 Methods and compositions for deuterated biologics Human Necessities 0 Active
US11224634B2 Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof General 0 Revoked
US12097242B2 Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides Human Necessities 0 Active
US11185570B2 Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides Human Necessities 0 Active
US12097241B2 Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides Human Necessities 0 Active
US11623965B2 Prodruggable antibodies, prodrugs thereof, and methods of use and making Chemistry; Metallurgy 0 Active
US12194110B2 PD-L1 binding polypeptides for imaging Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.